Back to User profile » Dr Lianxin Liu
Papers published by Dr Lianxin Liu:
Risk Factors for Recurrence in Patients with Hepatocellular Carcinoma After Curative Resection or Ablation
Meng F, Wang J, Zhu XD, Zhang M, Zhang X, Cheng D, Zhang X, Liu L
Journal of Hepatocellular Carcinoma 2025, 12:2501-2511
Published Date: 6 November 2025
Efficacy and Safety of Different Doses of Bevacizumab Combined with Atezolizumab in Unresectable Hepatocellular Carcinoma
Zhang S, Wang J, Zhu Z, Ji P, Wang Y, Cheng K, Nashan B, Liu L, Zhang S
Journal of Hepatocellular Carcinoma 2025, 12:2007-2015
Published Date: 31 August 2025
Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study
Sun HC, Huang ZY, Wen T, Liu L, Zhu XD, Zhang E, Li C, Zhang X, Wang J, Fan J, Zhou J
Journal of Hepatocellular Carcinoma 2025, 12:1043-1056
Published Date: 22 May 2025
Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant
Zhang S, Song R, Hou C, Yao H, Xu J, Zhou H, Li S, Cai W, Fei Y, Meng F, Yin D, Wang J, Zhang S, Liu Y, Wang J, Liu L
Journal of Hepatocellular Carcinoma 2025, 12:219-229
Published Date: 5 February 2025
Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
Cui TM, Liu Y, Wang JB, Liu LX
OncoTargets and Therapy 2020, 13:11725-11740
Published Date: 16 November 2020